← Leaderboards
Eugene C Butcher
Palo Alto Veterans Instit For Research
$31,504,079
Attributed
$31,749,964
Total exposure
25
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,749,964 · 23
VA$0 · 2
By mechanism
R01$22,890,149 · 13
R37$6,253,342 · 2
U19$1,003,023 · 1
R21$583,212 · 2
RC1$491,771 · 1
P50$304,477 · 1
Top collaborators
- Harry Bernard Greenberg1 shared
Others in their field
Top investigators on “Lymphocyte”
- Barton F Haynes · Duke University$408,040,925
- Lawrence Corey · Fred Hutchinson Cancer Center$299,247,526
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$157,640,776
- Dan H. Barouch · Fred Hutchinson Cancer Center$139,062,963
- James Dennis Neaton · Northwestern University$107,288,548
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
Research focus
LymphocyteImmune ResponseImmuneCellsResponseReceptorTraffickingImmunityInflammationTissuesInflammatoryHomingIn VivoMediatingInsightProgramsLeukocytesLeadFlow CytometryIntestinesBloodGenesLymph NodesChemokine
Grant awards (105)
Novel Lymphocyte Chemoattractant Receptor and Ligand$672,536
R01 · FY2025 · AI · contact PI
Progenitor Cells for High Endothelium in the Immune Response$638,103
R01 · FY2025 · AI · contact PI
Intestinal Lymphocyte Trafficking$394,396
R01 · FY2025 · AI · contact PI
Novel Lymphocyte Chemoattractant Receptor and Ligand$719,405
R01 · FY2024 · AI · contact PI
Progenitor Cells for High Endothelium in the Immune Response$638,104
R01 · FY2024 · AI · contact PI
Intestinal Lymphocyte Trafficking$403,063
R01 · FY2024 · AI · contact PI
Progenitor Cells for High Endothelium in the Immune Response$638,104
R01 · FY2023 · AI · contact PI
Tumor and Immune Programming of Tumor-AssociatedEndothelium$437,865
R01 · FY2023 · CA · contact PI
Intestinal Lymphocyte Trafficking$413,007
R01 · FY2023 · AI · contact PI
Intestinal Lymphocyte Trafficking$79,287
R01 · FY2023 · AI · contact PI
Intestinal Lymphocyte Trafficking$48,746
R01 · FY2023 · AI · contact PI
Tumor and Immune Programming of Tumor-AssociatedEndothelium$435,453
R01 · FY2022 · CA · contact PI
Intestinal Lymphocyte Trafficking$426,000
R01 · FY2022 · AI · contact PI
ShEEP Request for a Cytek Aurora Spectral Analyzer$0
IS1 · FY2022 · VA · contact PI
Progenitor Cells for High Endothelium in the Immune Response$509,659
R01 · FY2021 · AI · contact PI
Tumor and Immune Programming of Tumor-Associated Endothelium$441,760
R01 · FY2021 · CA · contact PI
Progenitor Cells for High Endothelium in the Immune Response$509,659
R01 · FY2020 · AI · contact PI
Tumor and Immune Programming of Tumor-Associated Endothelium$439,634
R01 · FY2020 · CA · contact PI
Intestinal Lymphocyte Trafficking$347,250
R37 · FY2020 · AI · contact PI
Progenitor Cells for High Endothelium in the Immune Response$509,659
R01 · FY2019 · AI · contact PI
Tumor and Immune Programming of Tumor-Associated Endothelium$452,421
R01 · FY2019 · CA · contact PI
Intestinal Lymphocyte Trafficking$347,250
R37 · FY2019 · AI · contact PI
Transcriptional Profiling of Human High Endothelial Venules$0
I01 · FY2019 · VA · contact PI
Progenitor Cells for High Endothelium in the Immune Response$509,659
R01 · FY2018 · AI · contact PI
Intestinal Lymphocyte Trafficking$347,250
R37 · FY2018 · AI · contact PI
Transcriptional Profiling of Human High Endothelial Venules$0
I01 · FY2018 · VA · contact PI
Progenitor Cells for High Endothelium in the Immune Response$426,837
R01 · FY2017 · AI · contact PI
Intestinal Lymphocyte Trafficking$347,250
R37 · FY2017 · AI · contact PI
Endothelial Cell Biology in Inflammation$312,525
R01 · FY2017 · GM · contact PI
Chemerin in Tumor Immunity and Surveillance$292,575
R01 · FY2017 · CA · contact PI
Chemerin in Tumor Immunity and Surveillance$80,422
R01 · FY2017 · CA · contact PI
Transcriptional Profiling of Human High Endothelial Venules$0
I01 · FY2017 · VA · contact PI
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function$347,500
R01 · FY2016 · AI · contact PI
Intestinal Lymphocyte Trafficking$347,250
R37 · FY2016 · AI · contact PI
Endothelial Cell Biology in Inflammation$312,525
R01 · FY2016 · GM · contact PI
Chemerin in Tumor Immunity and Surveillance$292,575
R01 · FY2016 · CA · contact PI
Chemerin in Tumor Immunity and Surveillance$80,422
R01 · FY2016 · CA · contact PI
Transcriptional Profiling of Human High Endothelial Venules$0
I01 · FY2016 · VA · contact PI
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function$447,500
R01 · FY2015 · AI · contact PI
Intestinal Lymphocyte Trafficking$347,500
R37 · FY2015 · AI · contact PI
Endothelial Cell Biology in Inflammation$312,525
R01 · FY2015 · GM · contact PI
Chemerin in Tumor Immunity and Surveillance$292,575
R01 · FY2015 · CA · contact PI
Chemerin in Tumor Immunity and Surveillance$67,365
R01 · FY2015 · CA · contact PI
Intestinal Lymphocyte Trafficking$347,500
R37 · FY2014 · AI · contact PI
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function$347,500
R01 · FY2014 · AI · contact PI
Chemerin in Tumor Immunity and Surveillance$283,798
R01 · FY2014 · CA · contact PI
Intestinal Lymphocyte Trafficking$326,650
R37 · FY2013 · AI · contact PI
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function$326,650
R01 · FY2013 · AI · contact PI
Chemerin in Tumor Immunity and Surveillance$292,575
R01 · FY2013 · CA · contact PI
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic Potential$279,849
R01 · FY2013 · DK · contact PI
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function$347,500
R01 · FY2012 · AI · contact PI
Intestinal Lymphocyte Trafficking$347,500
R37 · FY2012 · AI · contact PI
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic Potential$289,999
R01 · FY2012 · DK · contact PI
Intestinal Lymphocyte Trafficking$347,500
R37 · FY2011 · AI · contact PI
Regulation of T Cell CCR10 by Sunlight and Vitamin D$336,518
R01 · FY2011 · AI · contact PI
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic Potential$289,999
R01 · FY2011 · DK · contact PI
Mucosal Immunity and Influenza Vaccines: Phenotype and Role of Activated B Cells$491,771
RC1 · FY2010 · AI · contact PI
Tolerogenic DC as Therapeutic Agents in GVHD$358,000
R01 · FY2010 · AI · contact PI
Regulation of T Cell CCR10 by Sunlight and Vitamin D$339,917
R01 · FY2010 · AI · contact PI
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic Potential$326,066
R01 · FY2010 · DK · contact PI
Tolerogenic DC as Therapeutic Agents in GVHD$358,000
R01 · FY2009 · AI · contact PI
Regulation of T Cell CCR10 by Sunlight and Vitamin D$343,350
R01 · FY2009 · AI · contact PI
Intestinal Lymphocyte Trafficking$333,393
R01 · FY2009 · AI · contact PI
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic Potential$329,360
R01 · FY2009 · DK · contact PI
Novel Dendritic Cell Chemoattractant and Receptor$325,557
R01 · FY2009 · AI · contact PI
Protective Mechanisms Against Pandemic Respiratory Virus$1,003,023
U19 · FY2008 · AI · contact PI
Regulation of T Cell CCR10 by Sunlight and Vitamin D$343,350
R01 · FY2008 · AI · contact PI
Intestinal Lymphocyte Trafficking$333,393
R01 · FY2008 · AI · contact PI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$331,430
R37 · FY2008 · GM · contact PI
Novel Dendritic Cell Chemoattractant and Receptor$325,557
R01 · FY2008 · AI · contact PI
Regulation of T Cell CCR10 by Sunlight and Vitamin D$350,000
R01 · FY2007 · AI · contact PI
Intestinal Lymphocyte Trafficking$339,850
R01 · FY2007 · AI · contact PI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$331,453
R37 · FY2007 · GM · contact PI
Novel Dendritic Cell Chemoattractant and Receptor$297,322
R01 · FY2007 · AI · contact PI
Novel Dendritic Cell Chemoattractant and Receptor$33,166
R01 · FY2007 · AI · contact PI
Proteinase Regulators of Immune Cell Traffic Mechanisms$32,245
R03 · FY2007 · TW · contact PI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$331,476
R37 · FY2006 · GM · contact PI
Novel Dendritic Cell Chemoattractant and Receptor$312,480
R01 · FY2006 · AI · contact PI
Intestinal Lymphocyte Trafficking$292,071
R01 · FY2006 · AI · contact PI
FACS/ IMMUNOPROBE CORE$97,577
P30 · FY2006 · DK · contact PI
Intestinal Lymphocyte Trafficking$55,783
R01 · FY2006 · AI · contact PI
Proteinase Regulators of Immune Cell Traffic Mechanisms$33,208
R03 · FY2006 · TW · contact PI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$329,636
R37 · FY2005 · GM
CCR9 and TECK in Intestinal Lymphocyte Trafficking$258,967
R01 · FY2005 · AI
Mucosal epithelial chemokine (CCL28) in asthma$158,638
P50 · FY2005 · HL
Novel Dendritic Cell Chemoattractant and Receptor$133,334
R01 · FY2005 · AI
Proteinase Regulators of Immune Cell Traffic Mechanisms$40,960
R03 · FY2005 · TW
Novel Dendritic Cell Chemoattractant and Receptor$325,000
R21 · FY2004 · AI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$320,102
R37 · FY2004 · GM
CCR9 and TECK in Intestinal Lymphocyte Trafficking$258,770
R01 · FY2004 · AI
Conference on Leukocyte Trafficking$20,000
R13 · FY2004 · AI
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$301,940
R37 · FY2003 · GM
CCR9 and TECK in Intestinal Lymphocyte Trafficking$258,578
R01 · FY2003 · AI
VASCULAR-MONOCYTE ADHESION MOLECULE IN ATHEROGENESIS$312,399
R01 · FY2002 · HL
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$293,203
R37 · FY2002 · GM
CCR9 and TECK in Intestinal Lymphocyte Trafficking$258,393
R01 · FY2002 · AI
Mucosal epithelial chemokine (CCL28) in asthma$145,839
P50 · FY2002 · HL
Core--Fluorescent activated cell sorting/immunoprobe$0
P30 · FY2002 · DK
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$284,719
R37 · FY2001 · GM
CCR9 and TECK in Intestinal Lymphocyte Trafficking$193,212
R01 · FY2001 · AI
CHEMOATTRACTANT SIGNALING TO LEUKOCYTE INTEGRINS$192,713
R01 · FY2001 · GM
VASCULAR-MONOCYTE ADHESION MOLECULE IN ATHEROGENESIS$63,738
R01 · FY2001 · HL
ENDOTHELIAL CELL BIOLOGY IN INFLAMMATION$276,483
R37 · FY2000 · GM
CCR9 AND TECK IN INTESTINAL LYMPHOCYTE TRAFFICKING$258,212
R21 · FY2000 · AI
CHEMOATTRACTANT SIGNALING TO LEUKOCYTE INTEGRINS$187,176
R01 · FY2000 · GM